Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations
Open Access
- 29 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (4) , 676-680
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine — California, May 2022–May 2023MMWR. Morbidity and Mortality Weekly Report, 2023
- Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022Eurosurveillance, 2023
- Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccineEurosurveillance, 2023
- Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Breakthrough Infections after Postexposure Vaccination against MpoxNew England Journal of Medicine, 2022
- Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination?Infection, 2022